IVIG Access Issues Highlighted In Effort To Eliminate Specialty Drug Tiers

Continued problems with patient access to intravenous immune globulin therapies is helping patient advocacy groups put the spotlight on payers' handling of IVIG on their formularies and make a push for eliminating the use of specialty drug tiers